| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-22 |
| filingDate |
2003-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d1fdbacf61b941f80b00bacf2416b8b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_420a1d80633e7edd04ba2cb8a304b1df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea2c70d1f9e89c870dc16fd138cb6511
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8097a2c976b2b98bc71e24b71eed23b |
| publicationDate |
2004-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004110959-A1 |
| titleOfInvention |
Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| abstract |
Compounds having Formula I n n n or pharmaceutically acceptable salts or prodrugs thereof, are useful for treating pathological states which arise from or are exacerbated by angiogenesis. The invention also relates to pharmaceutical compositions comprising these compounds and to methods of inhibiting angiogenesis in a mammal. |
| priorityDate |
1998-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |